More articles from Letter

Open Access
Impact of pre-neoadjuvant radioactive iodine seed marking on pathologic complete response and survival in early-stage breast cancer patients
Yihao Geng, Qi Zhang, Zhao Bi, Zhiqiang Shi, Qiuchen Zhao, Xiaowei Qi, Rongrong Zhao, Yongsheng Wang and Pengfei Qiu

Cancer Biology & Medicine December 2025, 20250578; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0578
Open Access
Effectiveness of postoperative adjuvant radiochemotherapy versus radiotherapy in thoracic esophageal squamous cell carcinoma with lymph node metastasis: a multicenter randomized study
Jiangfeng Wang, Wenhui Shen, Xiaojiang Sun, Ding Wang, Youhua Jiang and Weimin Mao

Cancer Biology & Medicine December 2025, 22 (12) 1553-1557; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0479
Open Access
COX-2 inhibition synergizes with radioimmunotherapy by promoting TCF1⁺CD8⁺ T cell infiltration in NSCLC
Lin Ma, Menglin Bai, Yao Wang, Xueying Zhai, Jinming Yu and Xiangjiao Meng

Cancer Biology & Medicine December 2025, 22 (12) 1537-1543; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0205
Open Access
Immunotherapy rechallenge of patients with advanced NSCLC progression after sequential treatment with third-generation EGFR-TKI and immunotherapy
Shuyi Hu, Zipeng Wu, Yingying Dai, Xinhong Shi, Qin Hu, Caolu Liu, Yifei Zhu, Ruofan Yu, Jingwen Li, Ying Liu, Tianyi Liu, Lin Lu, Chengyun Yao, Bo Shen, Meiqi Shi, Cheng Chen, Xiaohua Wang and Guoren Zhou

Cancer Biology & Medicine December 2025, 22 (12) 1544-1552; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0393
Open Access
IL-17A blockade alleviates immune checkpoint inhibitor-associated psoriasiform rash: preclinical and clinical responses
Yuli Ruan, Mengde Shi, Yue Ma, Bojun Wang, Ming Ma, Tianjiao Dang, Yanqiao Zhang and Chao Liu

Cancer Biology & Medicine November 2025, 22 (11) 1372-1376; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0344
Open Access
Phase I clinical study of humanized BCMA-single-domain antibodies targeting CAR-T in patients with relapsed or refractory multiple myeloma
Gaofeng Zheng, Ruyi Xu, Heng Mei, Xiaoyan Han, Donghua He, Yanling Weng, Cheng Wen, Zhuoxiao Cao and Zhen Cai

Cancer Biology & Medicine November 2025, 22 (11) 1377-1380; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0581
Open Access
Radiomic model for preoperative prediction of mismatch repair deficiency in gastric cancer: a multicenter study integrating tumor sub-region radiomics and transcriptomics
Siwei Pan, Enze Li, Guoliang Zheng, Yi You, Yanqiang Zhang, Mengxuan Cao, Ruolan Zhang, Qing Yang, Yizhou Wei, Weiwei Zhu, Ke Shen, Chencui Huang, Jingxu Xu, Lijing Wang, Zaisheng Ye, Zhiyuan Xu and Can Hu

Cancer Biology & Medicine October 2025, 22 (10) 1210-1217; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0254
Open Access
Glofitamab vs. real-world regimens in Chinese patients with third- or later-line relapsed/refractory diffuse large B-cell lymphoma: an external control study
Keshu Zhou, Huijing Wu, Xia Zhao, Xiaohong Tan, Xiaojing Yan, Haisheng Liu, Liping Su, Yukun Lan, Jaihui Xu, Xiaohui Zhou, Yuerong Shuang and Huilai Zhang

Cancer Biology & Medicine October 2025, 22 (10) 1218-1222; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0104
Open Access
Human papillomavirus vaccination willingness under resource inequities: momentary intervention effects of an educational video
Yuxi Liu, Rujing Shi, Mengmeng Jia, Luodan Suo, Wenxuan Li, Luzhao Feng and Juan Li

Cancer Biology & Medicine September 2025, 22 (9) 1010-1016; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0400
Open Access
Global disparities in childhood neuroblastoma: trends, burden, and inequities from 1990 to 2021
Rui Zhang, Yang Bi, Feifei Bao, Feixia Pan, Weize Xu, Qiang Shu, Zhigang Liu and Daqing Ma

Cancer Biology & Medicine July 2025, 20250163; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0163

Main menu

User menu

Search

More articles from Letter

Pages

Navigate

More Information

For Authors

Journal Services